Results 151 to 160 of about 15,436 (169)

Transthyretin Amyloid Cardiomyopathy—Current and Future Therapies

Annals of Pharmacotherapy, 2021
Jankhna D Yadav, Paul P Belliveau
exaly  

Amyloid Cardiomyopathy: All That Sparkles Is Amyloid

Chest, 2014
Sameer Chadha, On Chen, Sunday Olatunde, Adnan Sadiq, Gerald Hollander, Jacob Shani   +5 more
openaire   +1 more source

Tafamidis Treatment Delays Structural and Functional Changes of the Left Ventricle in Patients With Transthyretin Amyloid Cardiomyopathy

European Heart Journal Cardiovascular Imaging, 2022
Christina Binder, Matthias Koschutnik, René Rettl   +2 more
exaly  

Tafamidis: A First-in-Class Transthyretin Stabilizer for Transthyretin Amyloid Cardiomyopathy

Annals of Pharmacotherapy, 2020
Hua Ling
exaly  

Effect of Tafamidis on Serum Transthyretin Levels in Non-Trial Patients With Transthyretin Amyloid Cardiomyopathy

JACC: CardioOncology, 2021
Sarah A M Cuddy, Rodney H Falk, Sharmila Dorbala   +2 more
exaly  

Unmasking the Prevalence of Amyloid Cardiomyopathy in the Real World: Results From Phase 2 of the AC-TIVE Study, an Italian Nationwide Survey

European Journal of Heart Failure, 2022
Marco Metra, Andrea Igoren Guaricci, Gianluca Di Bella   +2 more
exaly  

Amyloid Cardiomyopathy

2018
T. Sher, M.A. Gertz
openaire   +1 more source

Prevalence, Characteristics and Outcomes of Older Patients With Hereditary Versus Wild-Type Transthyretin Amyloid Cardiomyopathy

European Journal of Heart Failure, 2023
Marianna Fontana, Carol Whelan, Ambra Masi   +2 more
exaly  

Tafamidis Treatment for Patients With Transthyretin Amyloid Cardiomyopathy

New England Journal of Medicine, 2018
Mathew S Maurer, Arnt V Kristen, Giampaolo Merlini   +2 more
exaly  

Wild-Type Transthyretin Amyloid Cardiomyopathy

Circulation, 2016
Peter Liu, David Smyth
exaly